Cite

HARVARD Citation

    Gitelman, S. et al. (2021). Imatinib therapy for patients with recent-onset type 1 diabetes: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial. Lancet. 9 (8), pp. 502-514. [Online]. 
  
Back to record